. Author manuscript; available in PMC: 2013 Jun 19.

Published in final edited form as: Clin Microbiol Infect. 2010 Jun;16(6):10.1111/j.1469-0691.2010.03214.x. doi: 10.1111/j.1469-0691.2010.03214.x

TABLE 1.

Antibiotic options for the treatment of ampicillin- and vancomycin-resistant enterococcal infections

Food and Drug Administration approved	Not approved but potential clinical use	Investigational
Linezolid	Daptomycin	Oritavancin
Quinupristin-dalfopristin^*	Tigecycline^†	Ceftobiprole^‡
	Nitrofurantoin^§	Ceftaroline^‡
	Fosfomycin^§
	Doxycycline^¶, minocycline^¶
	Fluoroquinolones^¶
	Rifampin^¶
	Chloramphenicol

Only Enterococcus faecium.

^†

Not recommended as monotherapy.

^‡

Only Enterococcus faecalis.

^§

Only for uncomplicated urinary tract infections.

^¶

Only if susceptible and as part of a combination regimen.